The North America Sodium Alginate for Pharmaceutical Market has registered US$ 90.5 million in 2020, and projected to reach at US$ 121.9 million by 2028, growing at a CAGR of 3.8% during 2021-2028. Sodium Alginate applications include Active pharmaceutical ingredient which is most primary used in Antacids and to treat peptic ulcers. The sodium alginate companies provide specific grade as well general sodium alginate products directly to pharma companies. Grades of sodium alginate include anti-reflux, controlled release, solid dispersion, nano dispersion stabilizer, tissue engineering, and gelation type.
According to American College of Gastroenterology, 60 million Americans at least once a month and 15 million people daily suffer from acidity related problems. Moreover, In US 6.5 million patients are severely affected by chronic wound infections along with more than 18% of the diabetic patients over the age of 65 years are suffering from foot ulcers, which are not easily healed or repaired. The wound dressings by sodium alginate-based materials have more advantages in comparison to conventional gauze dressing as they provide moist environment in the wound areas and accelerates wound healing.
Seaweeds is the prime raw material for the manufacturing of sodium alginate. These seaweeds are either harvested from wild or from farms. North America is the 3rd largest importer of dried seaweeds and hydrocolloid products after China and European Union. Seaweed consumption in U.S is about 60% import dependent. Over the years, China and Philippines have been the major suppliers for semi processed seaweeds and processed sea weeds. The Covid-19 did not impact much in Sodium Alginate for Pharmaceutical market in North America region in terms of supplies but it impacted in terms of pricing. Asia Pacific countries such as China, Philippines and Indonesia are the major exporters of sodium Alginate to the North America regions which is used as API as well as excipients in the pharma industry.
According to American College of Gastroenterology, 60 million Americans at least once a month and 15 million people daily suffer from acidity related problems. Moreover, In US 6.5 million patients are severely affected by chronic wound infections along with more than 18% of the diabetic patients over the age of 65 years are suffering from foot ulcers, which are not easily healed or repaired. The wound dressings by sodium alginate-based materials have more advantages in comparison to conventional gauze dressing as they provide moist environment in the wound areas and accelerates wound healing.
By application, the North America Sodium Alginate for Pharmaceutical market has been categorized into API, and Excipients. The API segment is expected to be the dominant segment throughout the forecast period.
The U.S. is the largest market for the sodium alginate for pharmaceutical in the North American region. The U.S accounts for around 80% of the market share of sodium alginate in pharmaceutical market in 2017 and is expected to continue its dominance throughout the forecast period.
Some of the prominent companies involved in North America Sodium Alginate for Pharmaceutical Market includes DuPont, KIMICA corporation, Algaia and Qingdao Bright moon seaweed group co .
|
Attribute |
Details |
|
Study Period |
2017-2028 |
|
Base Year |
2020 |
|
Forecast Period |
2021-2028 |
|
Unit |
US$ Mn |
|
By Application |
|
|
By Country |
|
Choose License Type